Indivior Pharmaceuticals Inc
INDV
Kedudukan dalam Saham
#4015
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Harga Saham
$32.56
Disegerakkan terakhir: 2026-10-16
Modal Pasaran
$4.06B
Perubahan (1 hari)
-3.15%
Perubahan (1 tahun)
33.01%
Negara
US
Perdagangan Indivior Pharmaceuticals Inc (INDV)
Kategori
Healthcare
EPS untuk Indivior Pharmaceuticals Inc (INDV)
EPS setakat June 2026 TTM: $2.84
Menurut laporan kewangan terkini dan harga saham Indivior Pharmaceuticals Inc, EPS semasa syarikat (TTM) adalah $2.84. Pada akhir tahun 2023, syarikat mempunyai EPS sebanyak $0.01 peningkatan berbanding EPS tahun 2022 iaitu $-0.37.
Sejarah EPS untuk Indivior Pharmaceuticals Inc dari 2016 hingga 2026
EPS pada akhir setiap tahun
| Tahun | EPS | Ubah |
|---|---|---|
| 2026 (TTM) | $2.84 | 14,100.00% |
| 2024 | $0.02 | 3.42% |
| 2023 | $0.01 | -103.95% |
| 2022 | $-0.37 | -126.81% |
| 2021 | $1.38 | -227.78% |
| 2020 | $-1.08 | -213.68% |
| 2019 | $0.95 | -47.51% |
| 2018 | $1.81 | 330.95% |
| 2017 | $0.42 | 90.91% |
| 2016 | $0.22 | 0.00% |
EPS untuk syarikat atau pesaing yang serupa
| Syarikat | EPS | Perbezaan EPS | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -80.41% |
IN
|
